Jonathan W. Ayers's most recent trade in Idexx Laboratories, Inc. was a trade of 419,574 Common Stock done . Disclosure was reported to the exchange on Sept. 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 419,574 | 419,574 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 302,179 | 0 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 230,000 | 35,651 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Sep 2024 | 112,605 | 122,605 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 609 | 609 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 262 | 262 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 257 | 265,651 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 257 | 0 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 5,350 | 265,394 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | W. Ayers Jonathan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2024 | 1,000 | 271,594 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Ayers Jonathan W. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2024 | 850 | 270,744 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Ayers W. Jonathan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2023 | 2,424 | 272,594 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Aug 2023 | 492 | 135,547 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Aug 2023 | 1,000 | 136,039 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 10,000 | 95,540 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 10,000 | 105,540 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.54 per share. | 18 May 2023 | 10,000 | 147,039 (0%) | 0% | 79.5 | 795,400 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.54 per share. | 18 May 2023 | 10,000 | 147,039 (0%) | 0% | 79.5 | 795,400 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 487.84 per share. | 18 May 2023 | 2,753 | 143,286 (0%) | 0% | 487.8 | 1,343,011 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 487.82 per share. | 18 May 2023 | 2,254 | 143,647 (0%) | 0% | 487.8 | 1,099,539 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 489.71 per share. | 18 May 2023 | 2,242 | 140,032 (0%) | 0% | 489.7 | 1,097,926 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 490.77 per share. | 18 May 2023 | 1,695 | 138,337 (0%) | 0% | 490.8 | 831,858 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 492.82 per share. | 18 May 2023 | 1,426 | 140,213 (0%) | 0% | 492.8 | 702,757 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 488.77 per share. | 18 May 2023 | 1,308 | 142,339 (0%) | 0% | 488.8 | 639,317 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 491.91 per share. | 18 May 2023 | 1,298 | 137,039 (0%) | 0% | 491.9 | 638,494 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 494.28 per share. | 18 May 2023 | 1,229 | 138,984 (0%) | 0% | 494.3 | 607,465 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 486.92 per share. | 18 May 2023 | 1,138 | 145,901 (0%) | 0% | 486.9 | 554,116 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 488.63 per share. | 18 May 2023 | 1,012 | 142,274 (0%) | 0% | 488.6 | 494,498 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 486.48 per share. | 18 May 2023 | 1,000 | 146,039 (0%) | 0% | 486.5 | 486,482 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 495.93 per share. | 18 May 2023 | 886 | 138,098 (0%) | 0% | 495.9 | 439,398 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 497.66 per share. | 18 May 2023 | 759 | 137,339 (0%) | 0% | 497.7 | 377,721 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 491.59 per share. | 18 May 2023 | 400 | 141,639 (0%) | 0% | 491.6 | 196,636 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 498.48 per share. | 18 May 2023 | 300 | 137,039 (0%) | 0% | 498.5 | 149,544 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 490.03 per share. | 18 May 2023 | 300 | 142,039 (0%) | 0% | 490.0 | 147,008 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 645 | 645 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 257 | 257 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2023 | 3,514 | 137,039 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 1,685 | 140,209 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 344 | 0 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 344 | 140,553 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 May 2023 | 1,685 | 141,334 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 560 | 0 | - | - | Incentive Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 178.26 per share. | 09 May 2023 | 560 | 141,894 (0%) | 0% | 178.3 | 99,826 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 2,500 | 143,019 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 1 | 145,519 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Feb 2023 | 1,000 | 145,520 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2023 | 21,500 | 146,520 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Nov 2022 | 5,000 | 170,420 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Nov 2022 | 2,400 | 168,020 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2022 | 450,000 | 175,420 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2022 | 450,000 | 450,000 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2022 | 5,000 | 625,420 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 945 | 945 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 344 | 568 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 224 | 630,420 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 224 | 344 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 706 | 0 | - | - | Incentive Stock Option (right-to-buy) | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 141.60 per share. | 18 Feb 2022 | 706 | 630,196 (0%) | 0% | 141.6 | 99,970 | Common Stock |
| Idexx Laboratories | Jonathan W. Ayers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Feb 2022 | 8,000 | 629,740 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Jonathan W. Ayers | Director | Sale of securities on an exchange or to another person at price $ 509.70 per share. | 15 Feb 2022 | 250 | 629,490 (0%) | 0% | 509.7 | 127,425 | Common Stock |